PCOS, Depression and Anxiety: The Prevalence Data and What Helps

How much more likely is depression and anxiety with PCOS?

Women with PCOS have 3.78 times the odds of any depressive symptoms and 5.62 times the odds of any anxiety symptoms compared with women without it, in a systematic review and meta-analysis of 3,050 women with PCOS and 3,858 controls across 30 studies in 10 countries. The gap grows for symptoms severe enough to need treatment: an odds ratio of 4.18 for moderate-to-severe depressive symptoms and 6.55 for moderate-to-severe anxiety symptoms. When the analysis compared only women matched on BMI, the odds stayed elevated — 3.25 for depression and 6.30 for anxiety — which rules out body weight as the full explanation.

Is this just a reaction to having PCOS, or is there more to it?

Both — and odds ratios of 3.25 for depression and 6.30 for anxiety, found even after matching PCOS and control groups on BMI, show there is more to it than the obvious explanation. Living with visible symptoms — acne, hirsutism, hair thinning, an unpredictable cycle, fertility uncertainty — is a real and sufficient reason for distress on its own, and nothing here is meant to minimise that. But those BMI-matched figures held even when researchers controlled for weight, and a meaningful body of mechanistic work now argues PCOS and depression share biological ground rather than one simply causing the other through symptom burden.

A 2022 review lays out that overlap directly: both PCOS and depression are marked by elevated inflammatory markers, both involve disrupted regulation of cortisol and androgens, and both show associations with gut microbiome changes and vitamin D status — raising the possibility that inflammatory signalling crosses into the brain and contributes to mood symptoms directly, rather than mood simply trailing behind how a person feels about their symptoms. This is described as a plausible, biologically grounded hypothesis, not a settled causal mechanism — the review is explicit that the exact pathway “remains elusive.” What is not in doubt is that treating this as purely psychological, or purely a matter of “adjusting to diagnosis,” does not match what the data shows.

Is screening for this actually a guideline recommendation?

Yes — screening for depression and anxiety at the time of PCOS diagnosis has been a formal recommendation since 2018, not an informal suggestion.

The Androgen Excess-PCOS Society’s 2018 position statement concluded that screening for depressive and anxiety symptoms should be offered at the time of diagnosis, with screening for disordered eating also considered, based on its review of the prevalence data above. The 2023 international PCOS guideline carried this forward, specifically flagging the “very high prevalence of psychological features” as a broader disease feature clinicians need to recognise, alongside metabolic risk and sleep apnoea. If your PCOS diagnosis did not come with a mood screening conversation, that is a gap against the guideline, not a sign nothing is wrong — you are entitled to ask for one directly.

This runs in parallel with, not instead of, the blood work, ultrasound and cycle history that make up the rest of a PCOS diagnostic work-up. A mood screen adds a few minutes to an appointment that is already happening; it is a short, standardised questionnaire rather than an open-ended conversation, precisely so it does not depend on a person volunteering that something feels wrong. A positive score is a prompt for a further conversation and, if appropriate, a referral — not a diagnosis by itself.

What does a screening conversation actually look like?

A validated screen for depression or anxiety is typically a short, scored questionnaire covering the past two weeks — how often you have felt low, lost interest in things, felt anxious, or struggled to control worry — rather than a single “how are you feeling” question. It takes a few minutes, produces a numeric score with an established cutoff, and is designed to catch symptoms a person might otherwise minimise or attribute to something else entirely. None of that requires you to already suspect you are depressed or anxious before it is useful; that is the point of screening everyone rather than waiting for a self-report.

Does treating PCOS itself improve mood, or is that a separate project?

Mostly separate, and it is more honest to say so than to imply otherwise. The position statement behind the screening recommendation reviewed the available treatment studies and found only a small number that tested whether PCOS-directed treatments — lifestyle changes or medication — affected mood, and those showed no worsening and, in some cases, modest improvement. That is reassuring rather than compelling: treating PCOS is unlikely to make mood symptoms worse, but it is not established as a treatment for depression or anxiety in its own right. Regular movement, including the post-meal walking habit covered on this site, and consistent sleep are reasonable supports for mood generally, but they are not a substitute for direct mental health treatment if symptoms are moderate or severe.

What about mood swings specifically, rather than depression or anxiety?

The 4- to 6-fold odds increases above describe diagnosable depression and anxiety, not the day-to-day mood swings many people mean when they use that phrase — a related but far less-studied question. Irregular ovulation and the androgen fluctuations that come with it plausibly contribute to mood variability that does not fit neatly into a “depressed” or “anxious” category, working through the same cortisol and hormone-sensitive pathways discussed above, alongside the stress-cortisol loop covered elsewhere on this site. If swings are mild and track loosely with your cycle, that is a reasonable working explanation. If they are severe, sudden, or affecting relationships and work, treat that as a reason to be screened properly rather than to assume it is “just PCOS.”

Who this does not describe, and why screening still matters for everyone

Most women with PCOS do not have clinical depression or anxiety — an odds ratio of four to six-and-a-half describes a large relative increase over a baseline rate, not a majority outcome, and plenty of people manage the condition without significant mood symptoms. The reason universal screening still makes sense is that the people who are affected are not self-identifying reliably enough to be caught without it: symptoms get attributed to stress, to a hard year, or to the diagnosis itself being “just a lot to process,” and a validated screening conversation catches what a general check-in conversation misses.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same prevalence data on mood — only the label changed. This article uses PCOS, since that is still the term most readers search.

What to actually do next

Ask your GP or gynaecologist directly for a depression and anxiety screen if your PCOS diagnosis did not include one — you do not need to wait to be asked, and you do not need to be in crisis to make the request reasonable. If a screen comes back positive, treatment for depression and anxiety in PCOS is the same evidence-based menu used outside PCOS: therapy, medication, or both, prescribed by someone qualified to weigh it against anything else you are taking. Movement and sleep are worth doing regardless, covered in the lifestyle hub alongside the rest of what actually moves PCOS metabolic and mood markers — but they support treatment, they do not replace it.